Patients' preferences shed light on the murky world of guideline-based medicine

Journal of Evaluation in Clinical Practice

Volumn 13, Issue 1, 2007, Pages 154-159

  Penston, James ^a  

^a SCUNTHORPE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Concordance; Guidelines; Large scale randomized trials; Patients' preferences

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL RESEARCH; DECISION MAKING; ENVIRONMENT; FINANCIAL MANAGEMENT; HUMAN; INFORMATION; INTERPERSONAL COMMUNICATION; MEDICAL PRACTICE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; TIME; TREATMENT OUTCOME; VALIDITY;

COMMUNICATION; DECISION MAKING; HUMANS; PATIENT EDUCATION; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES;

EID: 33846930403     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2006.00701.x     Document Type: Article

References (60)

1. Barber, N. (1995) What constitutes good prescribing? British Medical Journal, 310, 923-925.
2. Royal Pharmaceutical Society of Great Britain Working Party. (1997) From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. London: Royal Pharmaceutical Society of Great Britain. Merck, Sharp and Dohme.
3. Ferner, R. E. (2003) Is concordance the primrose path to health? British Medical Journal, 327, 821-822.
4. Bridson, J., Hammond, C., Leach, A. & Chester, M. R. (2003) Making consent patient centred. British Medical Journal, 327, 1159-1161.
5. Towle, A. & Godolphin, W. (1999) Framework for teaching and learning informed shared decision making. British Medical Journal, 319, 766-769.
6. Elwyn, G., Edwards, A. & Britten, N. (2003) 'Doing prescribing': how doctors can be more effective. British Medical Journal, 327, 864-867.
7. Heath, I. (2003) A wolf in sheep's clothing: a critical look at the ethics of drug taking. British Medical Journal, 327, 856-858.
8. Braddock, C. H., Edwards, K. A., Hasenberg, N. M., Laidley, T. L. & Levison, W. (1999) Informed decision making in outpatient practice: time to get back to basics. Journal of the American Medical Association, 282, 2313-2320.
9. Stevenson, F. A., Barry, C. A., Britten, N., Barber, N. & Bradley, C. P. (2000) Doctor-patient communication about drugs: the evidence for shared decision making. Social Science and Medicine, 50, 829-840.
10. Britten, N., Stevenson, F. A., Barry, C. A., Barber, N. & Bradley, C. P. (2000) Misunderstandings in prescribing decisions in general practice: qualitative study. British Medical Journal, 320, 484-488.
11. Cox, K., Stevenson, F., Britten, N. & Dundar, Y. (2002) A Systematic Review of Communication Between Patients and Health Care Professionals About Medicine-Taking and Prescribing. London: GKT Concordance Unit, King's College.
12. Kennelly, C. & Bowling, A. (2001) Suffering in deference: a focus group study of older cardiac patients' preferences for treatment and perceptions of risk. Quality in Health Care, 10 (Supplement I), i23-i28.
13. Kessels, R. P. C. (2003) Patients' memory for medical information. Journal of the Royal Society of Medicine, 96, 219-222.
14. Lloyd, A. J., Hayes, P. D., London, N. J. M., Bell, P. R. & Naylor, A. R. (1999) Patients' ability to recall risk associated with treatment options. Lancet, 353, 645.
15. Taylor, C. & Ward, A. (2003) Patients' views of high blood pressure, its treatment and risks. Australian Family Physician, 32, 278-282.
16. Trewby, P. N., Reddy, A. V., Trewby, C. S., Ashton, V. J., Brennan, G. & Inglis, J. (2002) Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clinical Medicine, 2, 527-533.
17. Deber, R. B., Kraetschmer, N. & Irvine, J. (1996) What role do patients wish to play in treatment decision making? Archives of Internal Medicine, 156, 1414-1420.
18. Elwyn, G., Edwards, A. & Kinnersley, P. (1999) Shared decision-making in primary care: the neglected second half of the consultation. British Journal of General Practice, 49, 477-482.
19. McKinstry, B. (2000) Do patients wish to be involved in decision making in the consultation? A cross sectional survey with video vignettes. British Medical Journal, 321, 867-871.
20. Lewis, D. K., Robinson, J. & Wilkinson, E. (2003) Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes. British Medical Journal, 327, 841.
21. Ende, J., Kazis, L., Ash, A. & Moskowitz, M. (1989) Measuring patients' desire for autonomy: decision making and information seeking preferences among medical patients. Journal of General Internal Medicine, 4, 23-30.
22. Donovan, J. L. & Blake, D. R. (1992) Patient non-compliance: deviance or reasoned decision-making. Social Science and Medicine, 34, 507-513.
23. Britten, N. (1994) Patients' ideas about medicines: a qualitative study in a general practice population. British Journal of General Practice, 44, 465-468.
24. Benson, J. & Britten, N. (2002) Patients' decision about whether or not to take antihypertensive drugs. British Medical Journal, 325, 873-876.
25. Townsend, A., Hunt, K. & Wyke, S. (2003) Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. British Medical Journal, 327, 837-840.
26. Haynes, R. B., Devereaux, P. J. & Guyatt, G. H. (2002) Clinical expertise in the era of evidence-based medicine and patient choice. Evidence-Based Medicine, 7, 36-38.
27. Thornton, H. (2003) Patients' understanding of risk: enabling understanding must not lead to manipulation. British Medical Journal, 327, 693-694.
28. Alaszewski, A. & Horlick-Jones, T. (2003) How can doctors communicate information about risks more effectively? British Medical Journal, 327, 728-731.
29. McNeil, B. J., Pauker, S. G., Sox, H. C. & Tversky, A. (1982) On the elicitation of preferences for alternative therapies. New England Journal of Medicine, 306, 1259-1262.
30. Armstrong, K., Schwartz, J. S., Fitzgerald, G., Putt, M. & Ubel, P. A. (2002) Effect of framing as gain versus loss on understanding and hypothetical treatment choices. survival and mortality curve. Medical Decision Making, 22, 76-83.
31. Skolbekken, J.-A. (1998) Communicating the risk reduction achieved by cholesterol reducing drugs. British Medical Journal, 316, 1956-1958.
32. The EUROPA, investigators. (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet, 362, 782-788.
33. Naylor, C. D., Chen, E. & Strauss, B. (1992) Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Annals of Internal Medicine, 117, 916-921.
34. Forrow, L., Taylor, W. C. & Arnold, R. M. (1992) Absolutely relative: how research results are summarized can affect treatment decisions. American Journal of Medicine, 92, 121-124.
35. Bobbio, M., Demichelis, B. & Giustetto, G. (1994) Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet, 343, 1209-1211.
36. Bucher, H. C., Weinbacher, M. & Gyr, K. (1994) Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentrations. British Medical Journal, 309, 761-764.
37. Cranney, M. & Walley, T. (1996) Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. British Journal of General Practice, 46, 661-663.
38. Fahey, T., Griffiths, S. & Peters, T. J. (1995) Evidence based purchasing: understanding results of clinical trials and systematic reviews. British Medical Journal, 311, 1056-1059.
39. Malenka, D. J., Baron, J. A., Johansen, S., Wahrenberger, J. W. & Ross, J. M. (1993) The framing effect of relative and absolute risk. Journal of General Internal Medicine, 8, 543-548.
40. Montgomery, A. A., Harding, J. & Fahey, T. (2001) Shared decision making in hypertension: the impact of patient preferences on treatment choice. Family Practice, 18, 309-313.
41. Lewis, D. K. & Barton, S. (2003) Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups. Journal of Epidemiological Communications Health, 57, 241-242.
42. Steel, N. (2000) Thresholds for taking antihypertensive drugs in different professional and lay Groups: questionnaire survey. British Medical Journal, 320, 1446-1447.
43. McAlister, F. A., O'Connor, A. M., Wells, G., Grover, S. A. & Laupacis, A. (2000) When should hypertension be treated? The different perspectives of Canadian family physicians and patients. Canadian Medical Association Journal, 163, 403-408.
44. Rajagopal, S., Goodman, P. J. & Tannock, I. F. (1994) Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials. Journal of Clinical Oncology, 12, 1296-1304.
45. Friedmann, P. D., Brett, A. S. & Mayo-Smith, M. F. (1996) Differences in generalists' and cardiologists' perceptions of cardiovascular risk in the outcomes of preventive therapy in cardiovascular disease. Annals of Internal Medicine, 124, 414-421.
46. Pocock, S. J., Hughes, M. D. & Lee, R. J. (1987) Statistical problems in reporting clinical trials: a survey of three medical journals. New England Journal of Medicine, 317, 426-432.
47. Wells, G. A., Tugwell, P., Kraag, G. R., Baker, P. R. A., Goh, J. & Redelmeier, D. A. (1993) Minimum important difference between patients with rheumatoid arthritis: the patients' perspective. Journal of Rheumatology, 20, 557-560.
48. Moher, D., Dulberg, C. S. & Wells, G. A. (1994) Statistical power, sample size and their reporting in randomised controlled trials. Journal of the American Medical Association, 272, 122-124.
49. Guyatt, G. H., Juniper, E. F., Walter, S. D., Griffith, L. E. & Goldstein, R. S. (1998) Interpreting treatment effects in randomised trials. British Medical Journal, 316, 690-693.
50. Juniper, E. F. (1998) Quality of life questionnaires: does statistically significant = clinically important? Journal of Allergy and Clinical Immunology, 102, 16-17.
51. Chan, K. B. Y., Man-Song-Hing, M., Molnar, F. J. & Laupacis, A. (2001) How well is the clinical importance of study results reported? An assessment of randomised controlled trials. Canadian Medical Association Journal, 165, 1197-1202.
52. Jones, P. W. (2002) Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory, 19, 398-404.
53. Calman, K. C. & Royston, G. (1997) Personal paper: risk language and dialects. British Medical Journal, 315, 939-942.
54. Edwards, A., Elwyn, G. & Mulley, A. (2002) Explaining risks: turning numerical data into meaningful pictures. British Medical Journal, 324, 827-830.
55. Paling, J. (2003) Strategies to help patients understand risks. British Medical Journal, 327, 745-748.
56. Thomson, R., Edwards, A. & Grey, J. (2005) Risk communication in the clinical consultation. Clinical Medicine, 5, 465-469.
57. Penston, J. (2005) Large-scale randomised trials - a misguided approach to clinical research. Medical Hypotheses, 64, 651-657.
58. Charlton, B. G. (2001) Fundamental deficiencies in megatrial methodology. Current Controlled Trials in Cardiovascular Medicine, 2, 2-7.
59. Rees, J. L. (2003) Trials, evidence, and the management of patients with psoriasis. Journal of the American Academy of Dermatology, 48, 135-143.
60. Penston, J. (2003) Fiction and Fantasy in Medical Research: The Large-Scale Randomised Trial. London: The London Press.